-
Document de presse | 2004.09.19
New possibilities for fighting the plague
The plague, one of the most dangerous bacterial diseases for man, is currently reemerging in the world. Comparative genome work coordinated by researchers at Institut Pasteur and at Lawrence Livermore National Laboratory in the US, has shed light on the genetic bases that accompanied the emergence of the extremely virulent plague bacillus from a much less pathogenic ancestor, less than 20,000...
-
Document de presse | 2004.05.24
Stem Cells to Repair the Liver: Progress with animal models
Hepatic insufficiency, cirrhosis, liver cancer, etc.: damage to the liver is varied and in serious cases the only alternative is to transplant a healthy organ. However, the lack of available organs limits this practice: in France in 2002, 882 liver transplants were carried out for 1,509 transplant candidates.* Hope for the future is directed towards being able to transplant stem cells capable of...
-
Document de presse | 2004.03.14
A new step towards using neural stem celles to repair the brain
A team from the Institut Pasteur associated with the CNRS has just identified a key molecule in the brain capable of attracting new neurons and guiding them towards areas that they could repair. This discovery, previewed on the site Nature Neuroscience (http://www.nature.com/neuro/), brings to the fore a molecule essential for the organization of neuronal circuits in adults. This introduces...
-
Document de presse | 2004.02.19
Institut Pasteur/ Inserm : Joint research on the Nipah virus
Two teams from the Institut Pasteur and Inserm, in co-operation with Malaysian researchers, have recently successfully tested a candidate vaccine against the Nipah Virus. This virus, still undiscovered in 1998, was responsible for the deaths of 105 people in Malaysia in 1999. It is expanding at an alarming speed in South-East Asia. Currently there is no treatment in the fight against this...
-
Document de presse | 2004.01.19
A major advance in combatting Buruli ulcer
An international group of scientists coordinated by Stewart Cole of the Institut Pasteur has just discovered the genetic basis for the synthesis of the Mycobacterium ulcerans toxin, responsible for Buruli ulcer. Press release Paris, january 20, 2004 A rapidly-expanding emerging disease, Buruli ulcer is the one of the most common mycobacterial infections after...
-
Document de presse | 2013.07.04
Transmissibility of new coronavirus too low to trigger global epidemic at this stage
In a study published online on July 5, 2013 for the medical journal The Lancet, a team from the Institut Pasteur suggests that the coronavirus MERS-CoV, in its current form, is not capable of triggering a global epidemic. However, it should not be assumed that the virus’ transmissibility will not increase if the virus mutates or if transmission occurs at a one-off event where large numbers...
-
Document de presse | 2013.08.01
Dengue: identifying mosquito genetic factors that control virus transmission
Dengue is currently the most common insect-borne viral disease of humans worldwide. Scientists from the Institut Pasteur, the French National Center for Scientific Research (CNRS), and the Armed Forces Research Institute of Medical Sciences (AFRIMS) have discovered several genetic factors controlling the transmission of various dengue virus strains in a natural population of mosquitoes in...
-
Document de presse | 2013.09.30
Potential therapeutic targets for blocking AIDS virus replication
Scientists from the Institut Pasteur and Inserm have identified several proteins in humans as potential new therapeutic targets for treating the AIDS virus. These proteins are part of a complex cellular mechanism that blocks the virus replication in cells called macrophages. The discovery of this mechanism and the proteins involved gives scientists a solid theoretical basis for developing new...
-
Document de presse | 2013.10.09
Fine-tuning the approach to malaria and toxoplasmosis research
A study carried out by teams from the Institut Pasteur, the Institut Cochin (Inserm, CNRS, Paris Descartes University), and the Wellcome Trust Centre for Molecular Parasitology at the University of Glasgow, may very well redefine current approaches to malaria and toxoplasmosis research in terms of treatment development. Their research which focuses on the role played by the protein AMA1 (present...
-
Document de presse | 2013.11.03
Identification of a new mechanism in immunotherapy for lymphoma
Using innovative dynamic imaging technique, scientists at the Institut Pasteur, Inserm and the VU Medical Center in Amsterdam have uncovered the mode of action of anti-CD20, an antibody therapy frequently used in the treatment of lymphomas (cancers of the immune system) as well as some auto-immune diseases. In a lymphoma model, the scientists have been able to carry out real time in vivo imaging...